Cargando…

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients

PURPOSE: This secondary analysis of the prospective study on repeat [(18)F]fluoromisonidazole (FMISO)-PET in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) assessed the correlation of hypoxia in the primary tumour and lymph node metastases (LN) prior to and during prima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandurska-Luque, Anna, Löck, Steffen, Haase, Robert, Richter, Christian, Zöphel, Klaus, Perrin, Rosalind, Appold, Steffen, Krause, Mechthild, Steinbach, Jörg, Kotzerke, Jörg, Hofheinz, Frank, Zips, Daniel, Baumann, Michael, Troost, Esther G.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384311/ https://www.ncbi.nlm.nih.gov/pubmed/30834349 http://dx.doi.org/10.1016/j.ctro.2019.02.002

Ejemplares similares

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction
por: Starke, Sebastian, et al.
Publicado: (2023)

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)
por: Hölscher, Tobias, et al.
Publicado: (2022)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy
por: Jakobi, Annika, et al.
Publicado: (2015)

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy
por: Bütof, Rebecca, et al.
Publicado: (2017)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
por: Leger, Stefan, et al.
Publicado: (2020)

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
por: Zschaeck, Sebastian, et al.
Publicado: (2016)

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
por: Koi, Lydia, et al.
Publicado: (2023)

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
por: Leger, Stefan, et al.
Publicado: (2017)

[(68)Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study
por: Hoberück, Sebastian, et al.
Publicado: (2020)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
por: Rabasco Meneghetti, Asier, et al.
Publicado: (2022)

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy
por: Cordes, Nils, et al.
Publicado: (2018)

Suitability of bilateral filtering for edge-preserving noise reduction in PET
por: Hofheinz, Frank, et al.
Publicado: (2011)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

Dual time point based quantification of metabolic uptake rates in (18)F-FDG PET
por: den Hoff, Jörg van, et al.
Publicado: (2013)

A method for model-free partial volume correction in oncological PET
por: Hofheinz, Frank, et al.
Publicado: (2012)

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

PORTAF – postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation – study protocol for a randomized controlled trial
por: Bütof, R., et al.
Publicado: (2017)

Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
por: Schramm, Georg, et al.
Publicado: (2012)

Erratum to: Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
por: Schramm, Georg, et al.
Publicado: (2014)

Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes
por: Stützer, Kristin, et al.
Publicado: (2017)

Intraindividual comparison of [(68) Ga]-Ga-PSMA-11 and [(18)F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis
por: Hoberück, Sebastian, et al.
Publicado: (2021)

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients
por: Haase, Katharina, et al.
Publicado: (2021)

Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors
por: Rassamegevanon, Treewut, et al.
Publicado: (2018)

Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy
por: Bütof, Rebecca, et al.
Publicado: (2022)

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
por: Seidlitz, Annekatrin, et al.
Publicado: (2015)

18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
por: Zschaeck, Sebastian, et al.
Publicado: (2022)

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (†)
por: Sihver, Wiebke, et al.
Publicado: (2014)

Usefulness of FMISO—PET for Glioma Analysis
por: Kobayashi, Hiroyuki, et al.
Publicado: (2013)

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
por: Patil, Shivaprasad, et al.
Publicado: (2022)

Comparison of DCE‐MRI kinetic parameters and FMISO‐PET uptake parameters in head and neck cancer patients
por: Simoncic, Urban, et al.
Publicado: (2017)

Relative biological effectiveness in proton beam therapy – Current knowledge and future challenges
por: Lühr, Armin, et al.
Publicado: (2018)

Correction of scan time dependence of standard uptake values in oncological PET
por: van den Hoff, Jörg, et al.
Publicado: (2014)

Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET
por: Maus, Jens, et al.
Publicado: (2018)

FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
por: Dolezel, Martin, et al.
Publicado: (2022)

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes
por: Cubillos-Mesías, Macarena, et al.
Publicado: (2017)

Synthesis of [(18)F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective
por: Kniess, Torsten, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qqkrmdbeu6rqt0c1jpsgrcpnc7